Skip to main content
OpenTrials
Completed

NCT Number: NCT06105697

Effects of Aerobic Blood Flow Restriction

The aim is to evaluate the effects of aerobic blood flow restriction on academy football players. Randomized clinical trial, with two intervention groups: Experimental group I will carry out training based on running on the treadmill using blood flow restriction (BFR) on match days 4 and 3 pre-competition (MD-4, MD-3). On the other hand, the Experimental II group will perform the same training without the use of BFR for 6 weeks. The study will be carried out during the 2023-2024 season in the National and Youth Honor Divisions of Spanish soccer, with soccer teams from Mallorca Island. Before and after 6 weeks of intervention, the countermovement jump (CMJ), maximum aerobic speed (MAS), VO2max, and repeat sprint ability will be evaluated. The levels of muscle soreness (DOMS) will be evaluated at MD-4, MD-3, and MD-2. The same procedure will be carried out to evaluate muscle fatigue, sleep quality, and stress through a questionnaire. Sociodemographic and anthropometric data will be collected before starting the study. In addition, the rate of exertion perceived will be evaluated at MD-4, MD-3, and MD-2.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–25 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Christian, Palma de Mallorca, Balearic Islands, Spain

Loading trial locations.

About this study

The warm-up will consist of federation Internationale football association (FIFA) 11+. In addition, the warm-up will contain a familiarization with the jump test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-

Exclusion criteria

  • No injuries players

Treatment and study plan

Blood flow restriction Running on Treadmill

Other

Soccer players included in experimental group I will carry out this program for 6 weeks, setting the blood pressure to ~ 60% of limb occlusion pressure (AOP). They will run for 4 sets of 5 minutes, separated by 1 minute of rest, at 50-60% of their maximum Aerobic Speed.

Running on Treadmill

Other

Soccer players included in experimental group II will carry out the program for 6 weeks without occlude the blood pressure. They will run for 4 sets of 5 minutes, separated by 1 minute of rest, at 50-60% of their maximum Aerobic Speed.

Primary outcomes

  1. Change from Baseline in Countermovement Jump (CMJ)

    Time frame: Change from Baseline in countermovement Jump (CMJ Test) at 6 weeks

    CMJ Test measured by Force Platform (Vald Performance, Brisbane, Australia)

  2. Change from Baseline in Treadmill Incremental Test

    Time frame: Change from Baseline in Maximum Aerobic Speed at 6 Weeks

    Maximum Aerobic Speed (MAS) measured by the Treadmill Incremental test

  3. Change from Baseline in Repeat Sprint Ability

    Time frame: Change from Baseline in Repeat Sprint Ability at 6 Weeks

    Repeat Sprint Ability measured by the Bangsbo Test

  4. Change from Baseline In Yoyo Intermittent Recovery Test Level 1

    Time frame: Change from Baseline in Yoyo Intermittent Recovery Level 1 at 6 Weeks

    Vo2max Indirect measured by the Yoyo Intermittent Recovery Test Level I

Secondary outcomes

  1. Change from Baseline in Rating of Perceived Exertion (RPE)

    Time frame: Change from Baseline in RPE at Match Day -4 (MD-4), MD-3, MD-2 during the 6 Weeks´ Intervention

    Rating of Perceived Exertion (RPE) measured by Borg scale (0=Rest; 1=Really easy; 2=easy; 3=moderate; 4=sort of hard; 5=hard; 6=hard; 7=Really hard; 8= Really hard; 9= Really, really, hard; 10= Maximal)

  2. Change from Baseline in Fatigue

    Time frame: Change from Baseline in Fatigue at Match Day -4 (MD-4), MD-3, MD-2 during the 6 Weeks´ Intervention

    Fatigue measured by a Wellness Questionary (1= Always tired; 2=More tired than normal; 3=Normal; 4= Fresh; 5= Very fresh)

  3. Change from Baseline in Muscle Soreness

    Time frame: Change from Baseline in Muscle Soreness at Match Day -4 (MD-4), MD-3, MD-2 during the 6 Weeks´ Intervention

    Muscle Soreness measured by a Wellness Questionary (1=Very sore; 2= Increase in soreness/ tightness; 3=Normal; 4=Feeling good; 5=Feeling great)

  4. Change from Baseline in Sleep Quality

    Time frame: Change from Baseline in Sleep Quality at Match Day -4 (MD-4), MD-3, MD-2 during the 6 Weeks´ Intervention

    Sleep Quality measured by a Wellness Questionary (1=Insomnia; 2=Restless sleep; 3=Difficulty falling asleep; 4=good; 5=Very restful)

  5. Change from Baseline in Stress

    Time frame: Change from Baseline in Stress at Match Day -4 (MD-4), MD-3, MD-2 during the 6 Weeks´ Intervention

    Stress measured by a Wellness Questionary (1=Highly stressed; 2=Feeling stressed; 3=Normal; 4=Relaxed; 5=Very relaxed)

  6. Change from Baseline in Mood

    Time frame: Change from Baseline in Stress at Match Day -4 (MD-4), MD-3, MD-2 during the 6 Weeks´ Intervention

    Mood measured by a Wellness Questionary (1=Highly annoyed / irritable / down; 2=Snappy with team-mates, family and friends; 3=Less interested in others / activities; 4=Generally good mood; 5=Very positive mood)

Sponsors and collaborators

Lead sponsor

University of the Balearic Islands

Other

Registry information

Official study title

Effect of Aerobic Blood Flow Restriction Training in Academy Football Players: A Randomised Controlled Trial

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Oct 30, 2023
Registry last updated
Oct 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.